Increasing evidence suggests that SCFAs may have a beneficial role in adipose tissue, skeletal muscle and liver substrate metabolism, thereby contributing to improved insulin sensitivity and decrease in obesity 14, 15, 21. The gene discussed is INS; the disease is Obesity.